目的吡罗昔康乳膏的制备及稳定性研究。
ObjectiveTo study the preparation of piroxicam cream and its stability.
目的吡罗昔康乳膏的研制及稳定性研究。
OBJECTIVE To study the preparation and stability of piroxicam cream.
目的考察吡罗昔康凝胶的体外经皮离子导入。
OBJECTIVE to investigate the transdermal iontophoresis of piroxicam gel in vitro.
目的：研究吡罗昔康包合物混悬液的鼻粘膜吸收。
Objective: To investigate the suspension of inclusion compound of piroxicam nasal absorption.
结论吡罗昔康乳膏性质稳定，达到了质量标准的要求。
CONCLUSION the property of piroxicam cream was stable and reached the standard of the quality requirements.
目的评价氯诺昔康用于痔疮切除手术术后镇痛的效果和安全性。
To access the analgesic effects and safeness of intravenous Lornoxicam on postoperative analgesia following hemorrhoids operations.
目的：观察氯诺昔康预先镇痛应用于无痛人工流产手术的效果。
Objective: To observe the preemptive analgesia effect of lornoxicam during painless induced abortion.
目的：评价美洛昔康栓剂治疗强直性脊柱炎患者的疗效和安全性。
Objective: to evaluate the efficacy and safety of meloxicam suppository in treatment of ankylosing spondylitis.
目的：评价55例住院患者服用氯诺昔康的效果及其不良反应情况。
OBJECTIVE: To evaluate the analgesic efficacy and adverse drug reactions of Lornoxicam of55in-patient cases.
目的：评价氯诺昔康与曲马朵治疗甲状腺癌术后疼痛的效果及安全性。
Objective: to evaluate the effect and security of lornoxicam and tramadol in treating the postoperative pain of thyroid gland cancer.
应用线性扫描极谱法和循环伏安法对美洛昔康的极谱行为进行了研究。
The voltammetric behavior of meloxicam was studied using linear scan voltammetry and cyclic voltammetry.
目的：评价美洛昔康栓剂治疗强直性脊柱炎(as)患者的疗效和安全性。
Objective: to evaluate the efficacy and safety of meloxicam suppository in treatment of ankylosing spondylitis (AS).
目的：对氯诺昔康口腔崩解片的处方及制备工艺进行研究，并评价其质量。
Objective: To study the formulation and preparation of lornoxicam orally disintegrating tablets, and to evaluate its quality.
目的：观察美洛昔康对慢性铝过负荷致大鼠神经元退变的保护作用及其机制。
Objective To study the protective effects and mechanisms of meloxicam on neurodegeneration induced by chronic aluminum overload in rats.
目的：制备美洛昔康肠道内两次脉冲释药系统，并考察其体外释放影响因素。
Objective: To investigate two-pulse release tablets in intestinal tract of meloxicam, and to establish the method of drug release.
目的研究氯诺昔康两种给药方法对骨科椎间盘髓核摘除手术后镇痛效果的影响。
Objective The comparison of the effect of two methods of offering Lomoxicam to relieve pain used in intervertebral disc marrow nuclear excising operation.
结果：总有效率吡罗昔康组为90％，吲哚美辛组为77％（P＜0．05）。
RESULTS: The total effective rates were 90% for Pir and 77% for Ind (P<0.05).
结论经试验，大孔网格树脂的萃取回收率可达90 %以上，适用于血浆中替诺昔康的分析。
CONCLUSIONS Since the average extraction recovery of the macroreticular resin cartridge was more than 90%, it can be used in the analysis of tenoxicam in plasma samples.
吡罗昔康是一种用于治疗炎症的非类固醇抗炎药，该药物已上市多年并用于治疗多种疼痛症状。
Piroxicam is a NSAID, a medicine used to treat inflammation. It has been available on the market for many years and has been used in the treatment of many painful conditions.
此外，CHMP的结论还指出，含有吡罗昔康的药物不应再用于急性(短期)疼痛和炎症的治疗。
In addition, the CHMP has concluded that piroxicam-containing medicines should no longer be used for the treatment of acute (short-term) pain and inflammation.
欧洲药品管理局(emea)最近完成了有关非类固醇抗炎药(NSAID)吡罗昔康的安全性评价。
The European Medicines Agency (EMEA) has recently completed a review of the safety of the non-steroidal anti-inflammatory drug (NSAID) piroxicam.
结论氯诺昔康用于痔疮切除手术术后镇痛是安全、有效的，能减少阿片类镇痛药的用量，副作用更少。
Intravenous Lornoxicam can effectively provide postoperative pain relief for after hemorrhoids operations with high effect and safeness, and reduce the dosage of Opium.
结论氯诺昔康超前镇痛对腹腔镜胆囊切除术的术后镇痛效果确切，无明显不良反应，有推广应用价值。
Conclusions Lornoxicam preemptive analgesia on laparoscopic cholecystectomy exact analgesic effect, no significant adverse reactions have application value.
结论：吡罗昔康贴片治疗急慢性疼痛多项疗效指标结果优于双氯芬酸乳胶，安全性与双氯芬酸乳胶相似。
CONCLUSION: Piroxicam patch shows better efficacy and similar safety in the treatment of acute and chronic pain in comparing with diclofenac.
结论：氯诺昔康与曲马朵治疗甲状腺癌术后疼痛的效果相似，副反应低，使用氯诺昔康的满意度优于曲马朵。
Conclusion: lornoxicam and tramadol have similar effect in treating postoperative pain in thyroid gland cancer, while lornoxicam is superior to tramadol in the satisfaction degree.
此外，CHMP还增加了吡罗昔康某些禁忌症并强调了警告信息，以确保不用于那些出现副作用的高危患者。
In addition, the CHMP added some contraindications and strengthened warnings for piroxicam, to ensure that it is not used in patients who are at a higher risk of developing side effects.
目的：新型非甾体类抗炎药氯诺昔康能否降低大鼠切口疼痛，并探讨其可能的作用机制，主要研究其是否存在脊髓中枢作用机制。
Objective: to study whether or not lornoxicam reduced pain in the rat incision model and to discuss the possible mechanism, mainly discuss the mechanism of spinal cord center.
该局人用药品委员会(CHMP)的结论认为，吡罗昔康的益处仍大于其风险，但是，基于安全方面的考虑，其应用仅限于某些特定的适应症。
The Agency's Committee for Medicinal Products for Human Use (CHMP) has concluded that piroxicam's benefits still outweigh its risks, but, based on safety grounds, only in certain, limited indications.
用于释放活性物质的复合物，该复合物将活性物质限制在血液循环中或其它地方，这种复合物的例子如吡罗昔康倍他环糊精复合物或尼古丁倍他环糊精复合物。
Complexes intended to release an activesubstance that is entrapped by the complex in the blood circulation orelsewhere. Examples of such complexes are e. g. piroxicam betadex or nicotinebetadex.
用于释放活性物质的复合物，该复合物将活性物质限制在血液循环中或其它地方，这种复合物的例子如吡罗昔康倍他环糊精复合物或尼古丁倍他环糊精复合物。
Complexes intended to release an activesubstance that is entrapped by the complex in the blood circulation orelsewhere. Examples of such complexes are e. g. piroxicam betadex or nicotinebetadex.
应用推荐